Efficacy and safety of fezolinetant and its different doses in the treatment of vasomotor symptoms in menopausal women: a systematic review and meta-analysis
Abstract Introduction Fezolinetant, an oral NK3R antagonist, selectively blocks NKB signaling, improving vasomotor symptoms by reducing KNDy neuron activity. Our review assesses fezolinetant’s efficacy and safety in treating VMSs in menopausal women. Methods We conducted a systematic review and meta...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-06-01
|
| Series: | Middle East Fertility Society Journal |
| Online Access: | https://doi.org/10.1186/s43043-025-00231-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|